[The role of alpha1-adrenoblocker alfuzosine in diagnostic-therapeutic algorithm of hyperactive urinary bladder management in women and selection of patients for treatment with M-cholinergic antagonists].
In management of patients with hyperactive urinary bladder (HAUB) it is necessary to take into consideration the fact that long-term intake of M-cholinergic antagonists may result in obstructive miction because of low contractile activity of the urinary bladder. Use of M-cholinergic antagonists also problematic in detruzor dysfunction leading to slowing down of the urinary flow. In view of these possible complications, an algorithm of urodynamic diagnosis is proposed based on non-invasive registration of miction disorders using home uroflowmetry. Correction of detruzor contractility with dalfas combines well with cholinoblockers. In some cases administration of nontitrated alphablockers has no alternative especially in long-term treatment with mediators suppressing nonadapted detruzor contractions as it happens in HAUB. The above diagnosticotherapeutic algorithm of female miction disorders management which regards urine flow rates and comprises intake of alfusozine if necessary allows treatment of females with small urinary bladder when cholinergic antagonists are low-effective.
Danilov
V V
VV
Vol'nykh
I Iu
IIu
Danilova
T I
TI
Abdulaleva
S K
SK
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000465:Algorithms; D005260:Female; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014550:Urinary Incontinence, Stress / Q000175:diagnosis* / Q000188:drug therapy*; D014563:Urodynamics
D000317:Adrenergic alpha-Antagonists; D018727:Muscarinic Antagonists; D011799:Quinazolines; C047638:alfuzosin